The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical activity of systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma.
 
Joselle Cook
No Relationships to Disclose
 
Kah Whye Peng
Stock and Other Ownership Interests - Vyriad
Patents, Royalties, Other Intellectual Property - Vyriad
 
Susan Michelle Geyer
Research Funding - Brisol-Myers-Squibb (Inst)
 
Brenda F. Ginos
No Relationships to Disclose
 
Amylou C. Dueck
Patents, Royalties, Other Intellectual Property - Royalties from licensing fees for a patient symptom questionnaire (MPN-SAF)
 
Nandakumar Packiriswamy
No Relationships to Disclose
 
Lianwen Zhang
No Relationships to Disclose
 
Beth Brunton
No Relationships to Disclose
 
Baskar Balakrishnan
No Relationships to Disclose
 
Thomas E. Witzig
Consulting or Advisory Role - Abbvie/Genentech (Inst); ADC Therapeutics; Celgene (Inst); Cellectar; Epizyme; Incyte (Inst); Karyopharm Therapeutics; MorphoSys (Inst); Portola Pharmaceuticals; Seagen (Inst); Tessa Therapeutics
Research Funding - Acerta Pharma (Inst); Acrotech Biopharma (Inst); Celgene (Inst); Karyopharm Therapeutics (Inst); Kura Oncology (Inst)
Patents, Royalties, Other Intellectual Property - I am co-inventor on a patent application filed by Mayo Clinic and pending on the combination of CRM1 inhibitors with salicylates. Please note - simply filed - not even close to being granted. (Inst)
 
Stephen M Broski
No Relationships to Disclose
 
Mrinal Patnaik
Honoraria - Kura Oncology (Inst)
Consulting or Advisory Role - Kura Oncology (Inst)
Research Funding - Stemline Therapeutics (Inst)
 
Francis Buadi
No Relationships to Disclose
 
Angela Dispenzieri
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Prothena; Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
Morie A. Gertz
Honoraria - Abbvie; Akcea Therapeutics; Amgen; Apellis Pharmaceuticals; Celgene; Med Learning Group; Prothena; Research to Practice
Consulting or Advisory Role - Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena
 
Leif P. Bergsagel
No Relationships to Disclose
 
S. Vincent Rajkumar
Patents, Royalties, Other Intellectual Property - Authorship Royalties from Up To Date
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Cellectar; Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
Stephen J. Russell
Stock and Other Ownership Interests - Imanis Life Sciences; Vyriad
Patents, Royalties, Other Intellectual Property - As a Mayo Clinic employee I have filed invention disclosures and some of those have been filed as patents. I have assigned my rights in those patents to Mayo Clinic. (Inst)
Travel, Accommodations, Expenses - Vyriad
 
Martha Lacy
Research Funding - Celgene (Inst)